Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

Investor Presentation for the quarter and nine months ended December 31, 2023.
01-02-2024
Bigul

Thyrocare Technologies Ltd - 539871 - For The Quarter And Nine Months Ended December 31, 2023

Financial Results for the quarter and nine months ended December 31, 2023.
01-02-2024
Bigul

Thyrocare Technologies Ltd - 539871 - Board Meeting Outcome for For Financial Results For The Quarter And Nine Months Ended December 31, 2023

1. the unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2023. 2. appointment of Mr. Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer of the Company w.e.f. February 01, 2024;
01-02-2024
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Acquisition

We wish to inform you that Thyrocare Technologies Limited has entered into Share Purchase Agreement with Think Health Diagnostics Private Limited and existing shareholders of Think Health on February 1, 2024 at 12:30 pm (IST) to acquire 100% stake in Think Health from all the existing shareholders of Think Health.
01-02-2024
Bigul

Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Approval Of The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2023.

Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2024 ,inter alia, to consider and approve Board meeting intimation for Approval of The Unaudited Financial Results of The Company For The Quarter And Nine Months Ended 31St December 2023.
24-01-2024
Bigul

Thyrocare Technologies Ltd - 539871 - Closure of Trading Window

This is to to inform you that the Trading Window will be closed for dealing in securities of the Company by Designated Persons of the Company from January 01, 2024 and shall be remain closed upto 48 hours after declaration of the Financial Results for the Quarter ending December 31, 2023.
29-12-2023

Thyrocare Technologies share price may see 20% upside; ICICI Securities upgrades stock, raises target price

ICICI Securities has upgraded Thyrocare Technologies stock to Buy' from Add; earlier and raised the target price to 740 per share from 615.
14-12-2023

Buy Thyrocare Technologies; target of Rs 740: ICICI Securities

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.
13-12-2023
Next Page
Close

Let's Open Free Demat Account